Nuclear Medicine/Radiopharmaceuticals World Market Segmentation, Parameters and Major Players Analysis 2017 and Forecast 2021

 

HTF Market Intelligence released a new research report of 111 pages on title ‘Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2017

‘  with detailed analysis, forecast and strategies. The study covers key regions that includes  Europe, China, Japan.

 

Request a sample report @ https://www.htfmarketreport.com/sample-report/294637-global-nuclear-medicine-radiopharmaceuticals-market-2

 

 

Summary

In this report, the global Nuclear Medicine/Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

 

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

Global Nuclear Medicine/Radiopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Triad Isotopes

Nordion

Jubilant Pharma

Eli Lilly

Siemens

China Isotope & Radiation

Dongcheng

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Diagnostic

Therapeutic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nuclear Medicine/Radiopharmaceuticals for each application, including

Oncology

Thyroid

Cardiology

Other

 

 

 

 

 

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/294637-global-nuclear-medicine-radiopharmaceuticals-market-2

 

 

Table of Contents

 

Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2017

1 Nuclear Medicine/Radiopharmaceuticals Market Overview

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals

1.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type (Product Category)

1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)

1.2.2 Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Type (Product Category) in 2016

1.2.3 Diagnostic

1.2.4 Therapeutic

1.3 Global Nuclear Medicine/Radiopharmaceuticals Segment by Application

1.3.1 Nuclear Medicine/Radiopharmaceuticals Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Other

1.4 Global Nuclear Medicine/Radiopharmaceuticals Market by Region (2012-2022)

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Nuclear Medicine/Radiopharmaceuticals (2012-2022)

1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue Status and Outlook (2012-2022)

1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production Status and Outlook (2012-2022)

 

2 Global Nuclear Medicine/Radiopharmaceuticals Market Competition by Manufacturers

2.1 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Production and Share by Manufacturers (2012-2017)

2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Share by Manufacturers (2012-2017)

2.3 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type

2.5 Nuclear Medicine/Radiopharmaceuticals Market Competitive Situation and Trends

2.5.1 Nuclear Medicine/Radiopharmaceuticals Market Concentration Rate

2.5.2 Nuclear Medicine/Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

 

3 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Nuclear Medicine/Radiopharmaceuticals Capacity and Market Share by Region (2012-2017)

3.2 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Region (2012-2017)

3.3 Global Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

 

4 Global Nuclear Medicine/Radiopharmaceuticals Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Region (2012-2017)

4.2 North America Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

4.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

4.4 China Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

4.5 Japan Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

4.7 India Nuclear Medicine/Radiopharmaceuticals Production, Consumption, Export, Import (2012-2017)

 

5 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type

5.1 Global Nuclear Medicine/Radiopharmaceuticals Production and Market Share by Type (2012-2017)

5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2012-2017)

5.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2012-2017)

5.4 Global Nuclear Medicine/Radiopharmaceuticals Production Growth by Type (2012-2017)

 

6 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Application

6.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Application (2012-2017)

6.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

 

7 Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Profiles/Analysis

7.1 GE Healthcare

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Bracco Imaging

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Mallinckrodt

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Lantheus Medical Imaging

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Bayer

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Bayer Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Triad Isotopes

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Nordion

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Nordion Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Jubilant Pharma

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Eli Lilly

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Eli Lilly Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Siemens

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Siemens Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 China Isotope & Radiation

7.12 Dongcheng

 

8 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis

8.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

 

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2015

9.4 Downstream Buyers

 

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

 

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

 

12 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (2017-2022)

12.1 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2017-2022)

12.2 Global Nuclear Medicine/Radiopharmaceuticals Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Nuclear Medicine/Radiopharmaceuticals Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Application (2017-2022)

 

13 Research Findings and Conclusion

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/294637-global-nuclear-medicine-radiopharmaceuticals-market-2

 

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

 

 

 

 

 

 

 

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=294637

 

 

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

sales@htfmarketreport.com

Ph: +1 (206) 317 1218

 

%d bloggers like this: